ReviewClinical kidney journal2021
COVID-19 pandemic era: is it time to promote home dialysis and peritoneal dialysis?
Review in Clinical kidney journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 39 citations in OpenAlex.
- Lessons learned: management of acute kidney injury during COVID-19.Renal failure · 2026Article
- Risk and prognosis of Omicron infection in home-based dialysis patients: a retrospective cohort study in China.BMC nephrology · 2025Article
- Clinical effects of a home care program for patients with peritoneal dialysis in a tertiary care hospital.Kidney research and clinical practice · 2025Article
- Impact of COVID-19 pandemic on care of maintenance hemodialysis patients: a multicenter study.Clinical and experimental nephrology · 2024Observational
- The Burden of Home Dialysis: An Overlooked Challenge.Clinical journal of the American Society of Nephrology : CJASN · 2024Review
- The integrated care model: facilitating initiation of or transition to home dialysis.Clinical kidney journal · 2024Article
- Review
- Delivering Personalized, Goal-Directed Care to Older Patients Receiving Peritoneal Dialysis.Kidney diseases (Basel, Switzerland) · 2023Review
- Plasma vaspin levels and clinical outcome in incident peritoneal dialysis patients.BMC nephrology · 2023Article
- Choice of the Dialysis Modality: Practical Considerations.Journal of clinical medicine · 2023Review
- Circulating and Adipose Tissue Adiponectin Level and Outcomes in Incident Peritoneal Dialysis Patients.Kidney medicine · 2023Article
- Challenges to dialysis treatment during the COVID-19 pandemic: a qualitative study of patients' and experts' perspectives.Frontiers in psychology · 2023Article
- Excessive risk and poor outcome of hospital-acquired peritoneal dialysis-related peritonitis.Clinical kidney journal · 2022Article
- Randomized Study of Urgent-Start Peritoneal Dialysis Versus Urgent-Start Temporary Hemodialysis in Patients Transitioning to Kidney Failure.Kidney international reports · 2022Article
- Main Barriers to the Introduction of a Home Haemodialysis Programme in Poland: A Review of the Challenges for Implementation and Criteria for a Successful Programme.Journal of clinical medicine · 2022Review
- Ethical Issues in Kidney Transplant and Donation During COVID-19 Pandemic.Seminars in nephrology · 2022Review
- Urgent Start Peritoneal Dialysis: A Population-Based Cohort Study.Kidney medicine · 2022Article
- Fatality rate, risk factors, and functional decline in peritoneal dialysis patients with coronavirus disease 2019: A nationwide cohort study.Frontiers in medicine · 2022Article
- Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy.Renal replacement therapy · 2022Article
- COVID-19 and its impact on the kidney and the nephrology community.Clinical kidney journal · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The novel coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic in March 2020 by the World Health Organization. Older individuals and patients with comorbid conditions such as hypertension, heart disease, diabetes, lung disease, chronic kidney disease (CKD) and immunologic diseases are at higher risk of contracting this severe infection. In particular, patients with advanced CKD constitute a vulnerable population and a challenge in the prevention and control of the disease. Home-based renal replacement therapies offer an opportunity to manage patients remotely, thus reducing the likelihood of infection due to direct human interaction. Patients are seen less frequently, limiting the close interaction between patients and healthcare workers who may contract and spread the disease. However, while home dialysis is a reasonable choice at this time due to the advantage of isolation of patients, measures must be assured to implement the program. Despite its logistical benefits, outpatient haemodialysis also presents certain challenges during times of crises such as the coronavirus disease 2019 (COVID-19) pandemic and potentially future ones.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.